10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2011

Filing Information

Form Type	10-Q
Accession Number	`0001144204-11-063289`
Period End Date	20110930
Filing Date	20111114
Fiscal Year	2011
Fiscal Period	Q3
XBRL Instance	bpth-20110930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 51 Cash Flow Statement 56

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$567.25K	USD	Point-in-time
Cash	`Cash`	$238.56K	USD	Point-in-time
Cash	`Cash`	$105.58K	USD	Point-in-time
Cash	`Cash`	$983.29K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Grants receivable	`ReceivablesNetCurrent`	$244.48K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$88.40K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$52.03K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$72.99K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	56.15M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$644.44K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.04M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	49.40M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	49.40M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	56.15M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$3.04M	USD	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	473,334.00	shares	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	928,667.00	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$3.11M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$737.24K	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$579.75K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$2.37M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$2.46M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.40M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.11M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$88.40K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$43.13K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$84.14K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$111.86K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$50.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$74.22K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$205.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$246.76K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$246.76K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$205.00K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 56,146,296 and 49,400,605 shares issued and outstanding as of 9/30/11 and 12/31/10, respectively	`CommonStockValue`	$49.40K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 56,146,296 and 49,400,605 shares issued and outstanding as of 9/30/11 and 12/31/10, respectively	`CommonStockValue`	$56.15K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$11.75M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$9.72M	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$142.00K	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$278.60K	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$7.19M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$8.74M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.20M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.86M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.40M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.11M	USD	Point-in-time

Income Statement 51 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	3 Qtrs
Revenue	`Revenues`	-	USD	3 Qtrs
Revenue	`Revenues`	-	USD	18 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$265.94K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$1.00M	USD	3 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$327.38K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$832.52K	USD	3 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$5.85M	USD	18 Qtrs
Total operating expense	`OperatingExpenses`	$504.49K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$501.29K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$9.06M	USD	18 Qtrs
Total operating expense	`OperatingExpenses`	$1.42M	USD	3 Qtrs
Total operating expense	`OperatingExpenses`	$1.56M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-1.42M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-1.56M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-501.29K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-504.49K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-9.06M	USD	18 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.17K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$236.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$870.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.28K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$75.58K	USD	18 Qtrs
Other income	`OtherNonoperatingIncome`	$244.48K	USD	18 Qtrs
Other expense	`OtherNonoperatingExpense`	$285.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$200.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$3.37K	USD	18 Qtrs
Other expense	`OtherNonoperatingExpense`	$753.00	USD	3 Qtrs
Other expense	`OtherNonoperatingExpense`	$471.00	USD	3 Qtrs
Total Other Income	`NonoperatingIncomeExpense`	$530.00	USD	3 Qtrs
Total Other Income	`NonoperatingIncomeExpense`	$316.68K	USD	18 Qtrs
Total Other Income	`NonoperatingIncomeExpense`	$670.00	USD	1 Quarter
Total Other Income	`NonoperatingIncomeExpense`	$-49.00	USD	1 Quarter
Total Other Income	`NonoperatingIncomeExpense`	$1.70K	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-1.42M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-1.56M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-503.82K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-8.74M	USD	18 Qtrs
Net Loss	`NetIncomeLoss`	$-501.34K	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.21	USD	18 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	52.40M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	56.15M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	42.35M	shares	18 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	47.75M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberBasicDilutedSharesOutstanding`	49.08M	shares	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.42M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.56M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-503.82K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.74M	USD	18 Qtrs
Net loss	`NetIncomeLoss`	$-501.34K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$145.96K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$157.49K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$737.24K	USD	18 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$300.00K	USD	18 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$363.56K	USD	3 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$428.75K	USD	3 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$2.93M	USD	18 Qtrs
Grants receivable	`IncreaseDecreaseInReceivables`	$-244.48K	USD	3 Qtrs
Drug product for testing	`IncreaseDecreaseInInventories`	$-88.40K	USD	3 Qtrs
Drug product for testing	`IncreaseDecreaseInInventories`	$-77.26K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$52.03K	USD	18 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-20.97K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$35.61K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$205.00K	USD	18 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-41.76K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-192.85K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.62M	USD	18 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-726.16K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-995.58K	USD	3 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$752.20K	USD	18 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$175.44K	USD	3 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$62.55K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-175.44K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-62.55K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-752.20K	USD	18 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	$435.00K	USD	18 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$15.00K	USD	18 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.94M	USD	18 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$709.35K	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.53M	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.36M	USD	18 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$709.35K	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.53M	USD	3 Qtrs
NET INCREASE/(DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-461.67K	USD	3 Qtrs
NET INCREASE/(DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$744.72K	USD	3 Qtrs
NET INCREASE/(DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$983.29K	USD	18 Qtrs
Cash, beginning of period	`Cash`	$567.25K	USD	Point-in-time
Cash, beginning of period	`Cash`	$238.56K	USD	Point-in-time
Cash, beginning of period	`Cash`	$105.58K	USD	Point-in-time
Cash, beginning of period	`Cash`	$983.29K	USD	Point-in-time
Cash, end of period	`Cash`	$567.25K	USD	Point-in-time
Cash, end of period	`Cash`	$238.56K	USD	Point-in-time
Cash, end of period	`Cash`	$105.58K	USD	Point-in-time
Cash, end of period	`Cash`	$983.29K	USD	Point-in-time
Interest	`InterestPaid`	-	USD	18 Qtrs
Interest	`InterestPaid`	-	USD	3 Qtrs
Interest	`InterestPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	18 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	$420.00K	USD	18 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.